Pinpointing GI Bleeds: Olympus Experts Talk Hemostasis and Imaging Innovation

In this episode of DeviceTalks Weekly, Host Tom Salemi and managing editor Kayleen Brown recap their recent West Coast tour—including a stop at the Santa Clara Convention Center, home of DeviceTalks West on Oct. 15–16. Register at West.DeviceTalks.com. They also share highlights from the MedtechVISION conference, including Kayleen’s brush with greatness—the winner of the Ferolyn Powell Award. This week’s FOMO segment features Medtronic’s Julie Cole, who updates listeners on the latest challenges and opportunities in the ASC sector in a conversation with DeviceTalks producer Emira Wininger. In the keynote interview, Tom sits down with Bioretec’s new CEO, Sarah van Hellenberg Hubar-Fisher, to talk about her career in MedTech and her decision to lead the company’s mission to transform orthopedic healing with advanced materials and bioabsorbable implants. Thanks for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:03:30) - MedtechVISION and the Ferolyn Powell award(00:06:38) - the Ferolyn Powell award winner(00:09:00) - Exciting Updates and Keynotes at DeviceTalks West Conference(00:12:55) - Connected Health DeviceTalks Tuesdays series(00:15:18) - FOMO – Medtronic’s Julie Cole on the Future of ASCs and MedTech Innovation(00:25:40) - Keynote Interview - Sarah Hubar-Fisher, CEO of Bioretec(00:32:28) - Challenges and Triumphs in MedTech Regulatory and Market Adoption(00:35:37) - Hubar-Fisher’s Journey from Corporate to Venture Capital and BioRetech(00:41:40) - BioRetech's Innovative Magnesium Alloy Implants for Orthopedic Solutions(00:49:06) - Bioretech's Journey to Market Leadership in Bioabsorbable Implants

In this episode of DeviceTalks Weekly, Host Tom Salemi talks with Valeska Schroeder, CEO of Cerapedics, about her company’s success in developing drug-device combination products aimed at enhancing bone repair in spinal fusion surgeries. In this week’s FOMO session, Managing Editor Kayleen Brown explores the prospects of smart catheters with insights from Asheesh Divetia, head of engineering and technology at Cirtec Medical. For more information, go to cirtecmed.com. Later, MassDevice Editor Chris Newmarker brings this week’s Newsmakers - GE Healthcare, Edwards Lifesciences, Vectorious Medical, Kardium, Galvanize Therapeutics, and Solventum. Thank you for listening to the DeviceTalks Weekly podcast. ***Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

When a GI bleed strikes, the atmosphere in the procedure room changes instantly. In this episode of OlympusTalks, Olympus’ Christian Stroupe and Robert Barrett share how Olympus® technologies are designed to help physicians regain visibility and respond quickly to find the bleed and achieve hemostasis.  Chapter 1: Meet the Guests  Olympus’ Christian Stroupe and Robert Barrett explain their paths to medtech industry and their current roles in GI   Chapter 2: Why GI Bleeding Matters  The prevalence of GI bleeds and their impact on patient outcomes  Why it’s one of the top reasons for endoscopy  Chapter 3: The Moment Everything Changes  “You just see red everywhere” – how visibility is lost and urgency takes over  What it feels like when the room shifts from routine to critical  Chapter 4: Finding the Bleed  The challenge of pinpointing the source of the GI bleed  How advanced imaging helps physicians locate and assess the bleed  Chapter 5: Tools for Hemostasis  Overview of Olympus’ therapeutic options: clips, powders, and thermal forceps  Matching the right tool to the type of bleed  Chapter 6: Reducing Repeat Patient Visits  How effective hemostasis prevents rebleeds and follow-up procedures  Supporting physicians in getting it right the first time  Chapter 7: Hospital VS. ASC Settings  Difference in procedure complexity and patient profiles  Why even “routine” cases can present bleeding risks   For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts.  This podcast has been paid for by Olympus Corporation of the Americas.      ADDITIONAL RESOURCES:  Discover how the EVIS X1™ Endoscopy System is elevating the standard of care and the role of RDI™ technology: https://medical.olympusamerica.com/technology/rdi   Learn how EndoClot™ PHS, an advanced powder hemostat, supports physicians achieve hemostasis:   https://medical.olympusamerica.com/products/endoclotphs  Explore the Retentia™ HemoClip for reliable clipping and effective hemostasis during GI procedures:    https://medical.olympusamerica.com/products/retentia-hemoclip    *** Enjoy this podcast? Follow OlympusTalks on all major podcast players: https://olympustalks.castos.com/subscribe + Follow us on Yo... Chapters (00:01:18) - Meet the Guests(00:07:27) - Why GI Bleeding Matters(00:10:28) - Finding the Bleed(00:14:27) - The Moment Everything Changes(00:20:17) - Tools for Hemostasis(00:21:22) - Reducing Repeat Patient Visits(00:24:03) - Hospital VS. ASC Settings

In this week’s DeviceTalks Weekly, new Virtual Incision CEO Jim Alecxih walks us through his career, including a critical role at Intuitive Surgical, and explains why the Mira surgical robotic system convinced him to return to the industry. Olympus Ventures’ Abby Hunter-Syed keeps an eye on the broader tumult impacting MedTech. Chris Newmarker delivers the Newmarker’s Newsmakers – Insulet, Recor, Abbott, Ambu, GE Healthcare, Intuitive, Terumo and OrganOx. This episode is sponsored by DeviceTalks West. Check out the agenda and register at West.DeviceTalks.com. Thank you for listening to the DeviceTalks Podcast Network. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:50) - Show Open/Newmarker’s Newsmakers(00:05:25) - Insulet promotes Eric Benjamin to COO role(00:07:17) - Recor Medical's Paradise renal denervation tech wins Japanese approval(00:09:51) - Two Abbott MedTech executives leaving for new roles(00:13:03) - Intuitive announces layoffs?(00:16:35) - Terumo to acquire organ preservation device maker OrganOx for $1.5B(00:20:15) - FOMO – Abby Hunter-Syed, Sr. Director, Olympus Ventures(00:29:45) - Keynote – Jim Alecxih, CEO, Virtual Incision(00:37:07) - Early reactions to a surgical robot(00:42:40) - The Xbox /The Four Ps of Value Proposition(00:45:16) - Technology = Quality care(01:08:52) - Mira is different(01:10:12) - We're not a Ferrari. We’re an F150(01:14:57) - Message to patients

When a GI bleed strikes, the atmosphere in the procedure room changes instantly. In this episode of OlympusTalks, Olympus’ Christian Stroupe and Robert Barrett share how Olympus® technologies are designed to help physicians regain visibility and respond quickly to find the bleed and achieve hemostasis.  Chapter 1: Meet the Guests  Olympus’ Christian Stroupe and Robert Barrett explain their paths to medtech industry and their current roles in GI   Chapter 2: Why GI Bleeding Matters  The prevalence of GI bleeds and their impact on patient outcomes  Why it’s one of the top reasons for endoscopy  Chapter 3: The Moment Everything Changes  “You just see red everywhere” – how visibility is lost and urgency takes over  What it feels like when the room shifts from routine to critical  Chapter 4: Finding the Bleed  The challenge of pinpointing the source of the GI bleed  How advanced imaging helps physicians locate and assess the bleed  Chapter 5: Tools for Hemostasis  Overview of Olympus’ therapeutic options: clips, powders, and thermal forceps  Matching the right tool to the type of bleed  Chapter 6: Reducing Repeat Patient Visits  How effective hemostasis prevents rebleeds and follow-up procedures  Supporting physicians in getting it right the first time  Chapter 7: Hospital VS. ASC Settings  Difference in procedure complexity and patient profiles  Why even “routine” cases can present bleeding risks   For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts.  This podcast has been paid for by Olympus Corporation of the Americas.      ADDITIONAL RESOURCES:  Discover how the EVIS X1™ Endoscopy System is elevating the standard of care and the role of RDI™ technology: https://medical.olympusamerica.com/technology/rdi   Learn how EndoClot™ PHS, an advanced powder hemostat, supports physicians achieve hemostasis:   https://medical.olympusamerica.com/products/endoclotphs  Explore the Retentia™ HemoClip for reliable clipping and effective hemostasis during GI procedures:    https://medical.olympusamerica.com/products/retentia-hemoclip    *** Enjoy this podcast? Follow OlympusTalks on all major podcast players: https://olympustalks.castos.com/subscribe + Follow us on Yo...

In this episode of DeviceTalks Weekly, Editorial Director Tom Salemi sits down with Ken Charhut, executive chair and CEO of Foldax, to discuss how the startup’s polymer valve and robotic manufacturing process could offer a new alternative to traditional structural heart valves. David Niewolny, director of healthcare and medical business development at NVIDIA, joins as this week’s FOMO guest to share his vision for the future of technology in MedTech. Managing Editor Kayleen Brown and Salemi highlight the expanding FOMO library, preview the 2025 MedTech Nerd Tour, and celebrate a major milestone for the DeviceTalks Podcast Network. Explore our collection here: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4994542/future-of-medtech-opportunities-fomo Finally, MassDevice Editor Chris Newmarker returns with his Newmarkers Newsmakers, covering Medtronic, Philips, renal denervation, NeuroOne, and Novocure. Thank you for listening to the DeviceTalks Podcast Network. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Ethan Korngold, MD, Divisional Vice President, Medical Affairs and Chief Medical Officer of Abbott’s Vascular business, to discuss how artificial intelligence is reshaping decision-making in the cath lab and beyond. Dr. Korngold, an interventional cardiologist turned MedTech leader, discusses the evolution of Abbott’s vascular portfolio and how the company is integrating AI through platforms like Ultreon 2.0 to improve outcomes and procedural efficiency. The conversation covers specific applications of AI in intravascular imaging, vessel sizing, calcium detection, and future steps in stent placement guidance. He also addresses physician and hospital system perceptions of AI, why he sees it as a GPS-like tool for guiding physicians through complex procedures, and how it may soon impact pre- and post-procedural care.  This episode is brought to you by Resonetics. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8 Want to understand the history of nitinol? Make sure to check out Eric's Veit's Nitinol Innovation: Decade-by-Decade breakdown on LinkedIn: https://www.linkedin.com/posts/eric-veit_nitinol-innovation-decade-by-decade-resonetics-activity-7358601495631552512-hm9D?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAB4aLUBXtw-TjMHSa4dOuAiKreGeEZCZM4 *** Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/ Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Intro + Ethan Korngold's MedTech background(00:05:14) - Abbott's Vascular Innovations and AI Integration in Healthcare(00:08:54) - Innovations in Nitinol for Medical Device Manufacturing(00:12:44) - AI Revolutionizes Vascular Procedures with Enhanced Decision-Making(00:19:47) - The Future of Nitinol in Medical and Technological Applications(00:24:04) - AI's Role in Enhancing Medical Procedures and Patient Outcomes(00:27:14) - Life-Saving Coronary Interventions and Advanced Imaging Techniques(00:29:24) - AI Revolutionizing Cath Lab Procedures and Patient Care

In this episode of the DeviceTalks Weekly Podcast, Subsense CEO and Co-Founder Tetiana Aleksandrova shares how her company is using nanoparticles to establish brain-computer interfaces with the potential to deliver powerful new therapies to the brain. In her conversation with Host Tom Salemi, she reflects on her background, the impact of the war in her native Ukraine, and her previous work on neural interfaces. Earlier in the episode, AcuityMD Co-Founder and CEO Michael Monovoukas offers a look at the future of MedTech innovation (FOMO) in a conversation with Managing Editor Kayleen Brown. This episode is brought to you by AcuityMD. Learn more at www.acuitymd.com. Also, Yvonne Bokelman, Executive Director of MedtechWOMEN, previews the upcoming MedtechVISION conference taking place Sept. 9. Register at MedtechWOMEN.org. Finally, MassDevice Editor Chris Newmarker delivers his Newmarkers Newsmakers, featuring updates on Modular Medical, SetPoint Medical, Boston Scientific, Nyxoah, and OpenAI. Thank you for listening to the DeviceTalks Weekly podcast. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:20) - Newmarkers Newsmakers(00:06:21) - Modular Medical(00:08:18) - SetPoint Medical(00:10:14) - Boston Scientific(00:12:38) - Nyxoha(00:14:08) - OpenAI(00:16:22) - FOMO with Michael Monovoukas of AcuityMD(00:28:12) - Yvonne Bokelman, Executive Director, MedtechWOMEN(00:43:02) - Tetiana Aleksandrova, Co-Founder and CEO, Subsense(00:46:47) - Her origins/thoughts on the Russian invasion of her native Ukraine(00:52:18) - Origin of Subsense(00:56:20) - Nanoparticle technology(00:59:54) - Role of the nanoparticles

In this episode of the DeviceTalks Weekly podcast, iRhythm CEO Quentin Blackford shares his MedTech journey, the tech powering iRhythm’s arrhythmia detection, and what it takes to disrupt traditional healthcare. He talks patient engagement, predictive care, and the company’s push deeper into primary care. In this week’s FOMO, you’ll hear my interview with Zimmer Biomet CEO and President Ivan Tornos. We kick things off with MassDevice Editor Chris Newmarker’s Newmarker’s Newsmakers, covering Medtronic, Alcon, Staar Surgical, Inspire Medical, Edwards Lifesciences, and HistoSonics. Thanks for tuning in to DeviceTalks Weekly. *** Enjoy this episode? Follow DeviceTalks Weekly on your favorite podcast app and on YouTube.com/@DeviceTalks. Want full access to the DeviceTalks Podcast Network? Subscribe at https://devicetalks.castos.com/subscribe Chapters (00:02:04) - Newmarkers Newsmakers(00:06:10) - Medtronic(00:09:43) - Alcon(00:13:43) - Inspire Medical Systems(00:16:52) - Edwards Lifesciences(00:19:05) - HistoSonics(00:26:23) - FOMO Interview, Ivan Tornos, CEO & President, Zimmer Biomet(00:34:15) - Keynote Interview, Quentin Blackford, CEO, iRhythm(00:39:23) - Moving from CFO to CEO(00:42:43) - iRhythm overview(00:45:35) - What does profitability mean for a MedTech?(00:47:05) - Why does change take so long in healthcare?(00:51:00) - How do you engage with patients?(00:59:34) - Partnership with Lucem for predictive diagnostics(01:02:13) - Impact of Epic collaboration(01:06:57) - Importance of primary care physicians

In this episode of Ortho Innovation Talks, Terry Ross, Group President, Enovis™ Prevention & Recovery, shares how the company is reimagining orthopedic recovery through a combination of smart bracing technology and digital health platforms. Ross details how Enovis is prioritizing comfort and wearability in its bracing designs to drive better patient compliance, while also streamlining clinic operations through its MotionMD® workflow software. He also discusses MotionIQ®, a digital engagement tool designed to support patients throughout their rehab journey. With a focus on continuous improvement, Ross explains how Enovis is building connected solutions that improve patient outcomes and clinic efficiency—proving that externally applied devices can deliver powerful, tech-enabled care. This episode comes to you courtesy of our sponsor, Regenity. To learn more about how Regenity can help you 'make a material difference' please visit them at https://regenity.com. *** Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe